Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-20-031318

Director acquired 60 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Drutz David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-13 Exercise or conversion : show line 1 in the form +60 $2.40 $144 17,603 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-13 Exercise or conversion : show line 2 in the form Stock Options (option to buy) −60 0 D
Loading xslF345X03/doc4.xml…